hrIL-2

human recombinant interleukin-2

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hrIL-2, covering 2015-06-08 to 2015-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus [Phase 2]